RT @sam_debrouwer: Our study at @SharecareInc (Former @_doc_ai ) "Environmental Allergies from Real World Data Through a Mobile Study Plat…
RT @akshaysharma: Our study on allergy built on our Omix platform is now published in the Journal of Allergy and Asthma - https://t.co/JPJY…
Our study on allergy built on our Omix platform is now published in the Journal of Allergy and Asthma - https://t.co/JPJYhdEShn The study is using Real World Data with endpoint that resulted in a predictive allergy machine learning model.
RT @sam_debrouwer: Our study at @SharecareInc (Former @_doc_ai ) "Environmental Allergies from Real World Data Through a Mobile Study Plat…
@SharecareInc 💚 $FCAC LONG!
RT @sam_debrouwer: Our study at @SharecareInc (Former @_doc_ai ) "Environmental Allergies from Real World Data Through a Mobile Study Plat…
$FCAC
RT @sam_debrouwer: Our study at @SharecareInc (Former @_doc_ai ) "Environmental Allergies from Real World Data Through a Mobile Study Plat…
Our study at @SharecareInc (Former @_doc_ai ) "Environmental Allergies from Real World Data Through a Mobile Study Platform" is now published in the Journal of Asthma and Allergy @DovePress #allergies #AI #ClinicalResearch https://t.co/UPBFKztDhF
@SharecareInc 💚 $FCAC is not $TDOC, it's much, much more! https://t.co/E3yEIMw3EF https://t.co/m2kCuJ8ECG